Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders.
Authors
Gordan, Lucio N; Grow, William B; Pusateri, Annette; Douglas, Vonda; Mendenhall, Nancy P; Lynch, James W
Abstract
To determine the feasibility and efficacy of pharmacokinetic (PK) -based maintenance dosing of rituximab and possibly design a more rational maintenance schedule.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 6, p1096